Managing Director Sharvil Patel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Managing director sharvil patel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Managing Director Sharvil Patel Today - Breaking & Trending Today

Zydus aims to launch first new drug in US by early 2026

Zydus will enter a competitive field, with an FDA decision on CymaBay s PBC drug due in August. Gilead Sciences announced its acquisition of CymaBay for $4.3 billion earlier in February. Saroglitazar, currently in a mid-to-late-stage trial for PBC, is also being tested for Metabolic Dysfunction-Associated Steatohepatitis (MASH), a type of fatty liver disease." ....

United States , Zydus Lifesciences , Sun Pharma Cipla , Sharvil Patel , Novo Nordisk , Gilead Sciences , Managing Director Sharvil Patel , Primary Biliary Cholangitis , Metabolic Dysfunction Associated Steatohepatitis , Liver Disease , Early 2026 , New Drug , Sun Pharma ,

Lupin, Zydus Lifesciences ink licensing and supply pact for Saroglitazar Mg

Saroglitazar Mg, approved by the DCGI, is an innovative drug from Zydus to treat chronic liver diseases, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steato Hepatitis (NASH). ....

Nilesh Gupta , Sharvil Patel , Lupin Ltd , Zydus Lifesciences Ltd , Managing Director Nilesh Gupta , Managing Director Sharvil Patel , Zydus Lifesciences , Saroglitazar Mg , Non Alcoholic Fatty Liver Disease Nafld , On Alcoholic Steato Hepatitis Nash ,

Zydus Lupin: Lupin, Zydus Lifesciences ink licensing, supply pact for Saroglitazar Mg

Lupin and Zydus Lifesciences entered into a licensing and supply agreement to co-market Saroglitazar Mg, an innovative drug approved by India s DCGI for treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS. ....

Sharvil Patel , Nilesh Gupta , Zydus Lifesciences Ltd On , Lupin Ltd , Zydus Lifesciences Ltd , Nonalcoholic Steato Hepatitis , Managing Director Nilesh Gupta , Managing Director Sharvil Patel , Zydus Lupin , Saroglitazar Mg ,

World Moves From Shortages to Possible Glut of Covid-19 Vaccines

(Bloomberg) After racing to build capacity and meet once seemingly insatiable orders for Covid-19 shots, the global vaccine industry is facing waning demand as many late-to-market producers fight over a slowing market. ....

Andhra Pradesh , New Delhi , Gary Dubin , Astrazeneca Vaxzevria , Sharvil Patel , Kalbe Farma , Scott Rosenstein , Kiran Mazumdar Shaw , Adar Poonawalla , Mahima Datla , Zydus Lifesciences Ltd , World Health , Astrazeneca Plc , E Ltd , Japan Takeda Pharmaceutical Co , Pfizer Inc , Korea Genexine Inc , Moderna Inc , Eurasia Group , Biocon Ltd , Serum Institute Of India Ltd , Bloomberg Television , Airfinity Ltd , Mrna Technology , World Health Organization Backed , Bloomberg Intelligence ,

World moves from shortages to possible glut of COVID-19 vaccines

Even as boosters are likely to keep demand alive for COVID-19 inoculations worldwide, the desperate shortages that existed for much of last year have waned. ....

Andhra Pradesh , New Delhi , Gary Dubin , Astrazeneca Vaxzevria , Sharvil Patel , Kalbe Farma , Scott Rosenstein , Kiran Mazumdar Shaw , Adar Poonawalla , Mahima Datla , Zydus Lifesciences Ltd , Serum Institute Of India Ltd , Bloomberg Television , World Health , E Ltd , Japan Takeda Pharmaceutical Co , Pfizer Inc , Korea Genexine Inc , Moderna Inc , Eurasia Group , Biocon Ltd , Airfinity Ltd , World Health Organization Backed , Bloomberg Intelligence , New York Based , Managing Director Mahima Datla ,